ArticleClinical pharmacokinetics2023

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.

Hardik Chandasana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.